Berlin, Germany

Simon Boecker

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Technische Unversität Berlin. Active years: 2020.


% Patents Active = 100.0


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon Boecker: Innovator in Microbial Metabolite Production

Introduction

Simon Boecker is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of microbial biotechnology, particularly in the production of chimeric cyclooligodepsipeptides. His innovative methods have the potential to advance the understanding and application of microbial secondary metabolites.

Latest Patents

Simon Boecker holds a patent for a "Process for producing chimeric cyclooligodepsipeptides in filamentous fungi." This method involves obtaining at least one microbial secondary metabolite or a derivative thereof. The process includes the heterologous expression of at least one synthetase of the secondary metabolite in filamentous fungi. The patent also discloses an expression cassette, a plasmid vector that includes the expression cassette, an expression host, cyclodepsipeptides, and a chimeric cyclodepsipeptide synthetase. He has 1 patent to his name.

Career Highlights

Simon Boecker is affiliated with Technische Universität Berlin, where he engages in research and development in the field of biotechnology. His work focuses on innovative methods for producing valuable microbial compounds, contributing to advancements in the industry.

Collaborations

Simon collaborates with talented individuals such as Sophia Zobel and Agnes Muehlenweg. Their combined expertise enhances the research efforts at Technische Universität Berlin.

Conclusion

Simon Boecker is a pioneering inventor whose work in microbial metabolite production is paving the way for future innovations in biotechnology. His contributions are significant in advancing the field and hold promise for various applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…